Hip
Hip osteoarthritis burden increasing 'in almost all countries'
AAOS releases updated clinical practice guidelines for management of hip fractures
Quantitative joint space width sensitive to change, linked to hip osteoarthritis in women
Stronger hip structure, greater BMD observed in young women with obesity vs normal weight
Exeter Universal cemented stem for THA yielded ‘excellent’ long-term survivorship
Study: Polymerase chain reaction for PJI diagnosis is not useful as standalone test
Multiplex polymerase chain reaction, which uses polymerase chain reaction to simultaneously amplify several different next-generation DNA sequences, had 25.6% sensitivity when performed using Musculoskeletal Infection Society criteria for aspirate or tissue samples collected during 93 revision primary total joint arthroplasties and 77 primary total joint arthroplasties, according to study results.
Tanezumab 5 mg significantly improves pain, physical function in hip, knee OA
Among patients with hip or knee osteoarthritis, treatment with 5-mg doses of tanezumab statistically significantly improved pain, physical function and Patient’s Global Assessment of OA scores, while 2.5-mg doses achieved just two endpoints, according to data published in the Annals of the Rheumatic Diseases.